Weiss Multi-Strategy Advisers’s Evolent Health EVH Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-311,424	Closed	-$10.3M	–	167
2023 Q4	$10.3M	Buy	311,424 +201,033	+182%	+$5.69M	0.25%	99
2023 Q3	$3.01M	Buy	110,391 +28,642	+35%	+$796K	0.07%	319
2023 Q2	$2.48M	Sell	81,749 -71,922	-47%	-$2.33M	0.05%	437
2023 Q1	$4.99M	Sell	153,671 -17,098	-10%	-$541K	0.12%	264
2022 Q4	$4.79M	Buy	170,769 +53,414	+46%	+$1.53M	0.14%	234
2022 Q3	$4.22M	Buy	117,355 +27,700	+31%	+$976K	0.11%	270
2022 Q2	$2.75M	Buy	+89,655	New	+$2.61M	0.08%	331
2017 Q4	–	Sell	-55,000	Closed	-$979K	–	591
2017 Q3	$979K	Buy	+55,000	New	+$1.13M	0.04%	378

Other funds holding EVH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

Weiss Multi-Strategy Advisers's EVH Position: Q1 2024 in Review

Weiss Multi-Strategy Advisers sold out of Evolent Health (EVH) in Q1 2024, closing a stake of 311,424 shares — an estimated $10.3M sold.

Weiss Multi-Strategy Advisers first reported a position in EVH in Q3 2017 and held it in 8 quarters. The position peaked at $10.3M in Q4 2023. 251 funds tracked by Wall St. Rank hold EVH as of Q1 2024.

Weiss Multi-Strategy Advisers reported no remaining Evolent Health position as of Q1 2024 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 311,424 Evolent Health shares in Q1 2024, an estimated $10.3M.
Weiss Multi-Strategy Advisers first reported a position in Evolent Health in Q3 2017 and held it in 8 quarters.
Weiss Multi-Strategy Advisers's Evolent Health position peaked at $10.3M in Q4 2023.
251 funds tracked by Wall St. Rank held Evolent Health as of Q1 2024.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.